banner add

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

from NYT > Health https://ift.tt/MFGJ3z1
via IFTTT

No comments

Divisive F.D.A. Vaccine Regulator Resigns

Dr. Vinay Prasad drew criticism for decisions that overrode agency scientists and rejected potential drugs. from NYT > Health https://i...

Theme images by PLAINVIEW. Powered by Blogger.